Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone to High-Dose Treatment With ASCT in the Initial Management of Myeloma in Patients up to 65 Years of Age

NCT01191060 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT01191060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01191060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone to High-Dose Treatment With ASCT in the Initial Management of Myeloma in Patients up to 65 Years of Age
Lead sponsor
University Hospital, Toulouse
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2010
Completion date
November 30, 2018
Enrollment
700 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

myeloma